The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs: 1 blog

twitter: 1 X user

Citations

dimensions_citation: 86 Dimensions

Readers on

mendeley: 104 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 792 followers.

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma. - PubMed - NCBI https://t.co/4L8N3cTtFh

29 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.